ArticleClinical rheumatology2025
Factors predisposing to limited flexion after total hip arthroplasty for the treatment of axial spondyloarthritis.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [A long-term review for radiographic parameters of hips in axial spondyloarthritis patients with end-stage hip involvement: A 24-year trend analysis from a single high-volume tertiary center].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Hip involvement is a common condition in about one-third of patients with axial spondyloarthritis (axSpA). We assessed the incidence of possible factors that predispose patients to limited flexion after total hip arthroplasty (THA) for the treatment of axSpA. We retrospectively reviewed 516 patients with axSpA (759 hips) who underwent THA. Baseline patient demographics and clinical, laboratory, and surgery-related parameters were retrospectively collected. The preoperative and latest follow-up Harris hip score (HHS) and hip flexion ability were compared. After documenting the degree of postoperative hip flexion at the latest follow-up visit, we classified hips into good flexion group (> 90°) and poor flexion group (≤ 90°). The differences of baseline parameters between good flexion and poor flexion group were examined. Then those baseline parameters with P < 0.1 in intergroup comparisons were further included into the multivariate logistic models. The median duration of follow-up was 118.5 months (range, 25.0-269.1 months). The median HHS increased from 36.0 (25.0, 44.0) before surgery to 85.0 (77.0, 92.0) at the latest follow-up visit (P < 0.001). At the latest follow-up visit, 406 hips (53.5%) had hip flexion > 90°. The patients who were somewhat dissatisfied represented 147 hips (19.4%), and those who were very dissatisfied represented 46 hips (6.1%). The primary cause of dissatisfaction was limited range of motion (ROM) (323 hips, 80.1%). The multivariate logistic regression model revealed that the significant variables for postoperative poor hip flexion were the younger age of disease onset (OR = 0.967; P = 0.024), psoriasis (PSO) (OR = 2.071; P = 0.007), elevated C-reactive protein (CRP) (OR = 1.031; P < 0.001), and the lack of direct anterior approach (DAA) (OR = 0.372; P = 0.015). Although THA reconstruction for axSpA patients with end-stage hip involvement achieved encouraging clinical outcomes, it was prone to a restriction of hip flexion, which is closely associated with patient satisfaction. The younger age of disease onset, PSO, elevated CRP and the lack of DAA were significantly associated with limited postoperative hip flexion. Key Points • The restriction of hip flexion after THA reconstruction for axSpA patients is closely associated with patient satisfaction. • The younger age of disease onset, PSO, elevated CRP and the lack of DAA were significantly associated with limited postoperative hip flexion.
Indexed as
Identifiers
39869259What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.